SBC Medical Group Holdings Incorporated
SBC
$3.69
-$0.04-1.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -16.32% | -0.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.32% | -0.03% | |||
| Cost of Revenue | 7.13% | -28.04% | |||
| Gross Profit | -21.66% | 9.69% | |||
| SG&A Expenses | -2.93% | 144.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -235.75% | 1.54% | |||
| Total Operating Expenses | -37.21% | 52.07% | |||
| Operating Income | 42.95% | -49.31% | |||
| Income Before Tax | -53.77% | -51.61% | |||
| Income Tax Expenses | -104.76% | 20.45% | |||
| Earnings from Continuing Operations | 131.01% | -84.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -443.75% | 97.81% | |||
| Net Income | 130.83% | -84.67% | |||
| EBIT | 42.95% | -49.31% | |||
| EBITDA | 39.42% | -47.18% | |||
| EPS Basic | 113.42% | -98.72% | |||
| Normalized Basic EPS | 182.83% | -95.74% | |||
| EPS Diluted | 318.46% | -98.72% | |||
| Normalized Diluted EPS | 182.83% | -95.74% | |||
| Average Basic Shares Outstanding | 8.06% | 1,096.32% | |||
| Average Diluted Shares Outstanding | 8.06% | 1,096.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||